Evidence map›Paper›PMID 39681908›Full record

ArticleBMC global and public health2024

Stigma, depression, and quality of life among people with pulmonary tuberculosis diagnosed through active and passive case finding in Nepal: a prospective cohort study.

Kritika Dixit, Bhola Rai, Tara Prasad Aryal, Noemia Teixeira de Siqueira-Filha, Raghu Dhital, Manoj Kumar Sah, Ram Narayan Pandit, Govinda Majhi, Puskar Raj Paudel, Jens W Levy and 10 more

Abstract read
In one paragraph

Article in BMC global and public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The effects of stigma and social support on the health-related quality of life of people with drug resistance tuberculosis in Lagos, Nigeria.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kritika DixitBirat Nepal Medical Trust, Kathmandu, Nepal.
Bhola RaiBirat Nepal Medical Trust, Kathmandu, Nepal.
Tara Prasad AryalBirat Nepal Medical Trust, Kathmandu, Nepal.
Noemia Teixeira de Siqueira-FilhaDepartment of Health Sciences, University of York, York, UK.
Raghu DhitalBirat Nepal Medical Trust, Kathmandu, Nepal.
Manoj Kumar SahBirat Nepal Medical Trust, Kathmandu, Nepal.
Ram Narayan PanditBirat Nepal Medical Trust, Kathmandu, Nepal.
Govinda MajhiBirat Nepal Medical Trust, Kathmandu, Nepal.
Puskar Raj PaudelBirat Nepal Medical Trust, Kathmandu, Nepal.
Jens W LevyKNCV Tuberculosis Foundation, The Hague, Netherlands.
Job van RestKNCV Tuberculosis Foundation, The Hague, Netherlands.
Suman Chandra GurungBirat Nepal Medical Trust, Kathmandu, Nepal.
Gokul MishraCentre for Tuberculosis Research, Departments of International Public Health and Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Knut LönnrothDepartment of Global Public Health, WHO Collaborating Centre On TB and Social Medicine, Karolinska Institutet, Stockholm, Sweden.
Stephen Bertel SquireCentre for Tuberculosis Research, Departments of International Public Health and Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK.
Kristi Sidney AnnerstedtDepartment of Global Public Health, WHO Collaborating Centre On TB and Social Medicine, Karolinska Institutet, Stockholm, Sweden.
Laura BonnettInstitute of Population Health, University of Liverpool, Liverpool, UK.
Ahmad FuadyFaculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Maxine CawsBirat Nepal Medical Trust, Kathmandu, Nepal.
Tom WingfieldDepartment of Global Public Health, WHO Collaborating Centre On TB and Social Medicine, Karolinska Institutet, Stockholm, Sweden. tom.wingfield@lstmed.ac.uk.ORCID http://orcid.org/0000-0001-8433-6887

Funding

Horizon 2020 733174Medical Research Council MR/V004832/1Medical Research Council, Department for International Development, and Wellcome Trust (Joint Global Health Trials) MR/V004832/1National Medical Research Council APP2293the Medical Research Foundation (Dorothy Temple Cross International Collaboration Research Grant) MRF-131-0006-RG-KHOS-C0942Wellcome TrustWellcome Trust 209075/Z/17/Z
6 · The paper itself

Abstract

backgroundThe psychosocial consequences of tuberculosis (TB) are key barriers to ending TB globally. We evaluated and compared stigma, depression, and quality of life (QoL) among people with TB diagnosed through active (ACF) and passive (PCF) case-finding in Nepal.

methodsWe prospectively recruited adults with TB diagnosed through ACF and PCF in four districts of Nepal between August 2018 and April 2019. Participants were interviewed at 8-12 weeks (baseline) and 22-26 weeks (follow-up) following treatment initiation. TB stigma was measured using an adapted Van Rie Stigma Scale (0 = no stigma to 30 = highest stigma). Depression was measured using a locally-validated Patient Health Questionnaire (PHQ-9). Mild and major depression were indicated by  PHQ-9 scores 5-9 and ≥ 10, respectively. QoL was measured using the EuroQoL 5-Dimension 5-level (EQ-5D-5L) from 0 to 1 (optimal QoL); and self-rated health from 0 to 100 (optimal self-rated health).

resultsWe recruited 221 participants (111 ACF; 110 PCF) with a mean age of 48 years (standard deviation [SD] =  ± 16), of whom 147/221 (67%) were men. The mean TB stigma score was 12 (SD = 7.3) at baseline and 12 (SD = 6.7) at follow-up. The most commonly perceived elements of TB stigma at baseline were that people with TB experienced guilt (110/221, 50%) and feared disclosure outside their household (114/221, 52%). Self-rated health and EQ-5D-5L scores increased from baseline to follow-up (69.3 to 80.3, p < 0.001; 0.92 to 0.9, p = 0.009). Nearly one-third of participants (68/221, 31%) had mild or major depression at baseline. The proportion of participants with major depression decreased from baseline to follow-up (11.5% vs. 5%, p = 0.012). There was a moderate, significant positive correlation between depression and stigma scores (r = 0.41, p < 0.001). There were no differences found in TB stigma, self-rated health, QoL, or prevalence of mild/major depression between ACF and PCF participants.

conclusionsWe found a substantial, persistent, and clustered psychosocial impact among adults with TB diagnosed through both ACF and PCF strategies in Nepal. These findings suggest an urgent need to develop effective, evidence-based psychosocial support interventions with the potential to be integrated with existing ACF strategies and routine TB service activities.

Indexed as

Active case findingDepressionNepalPassive case findingQuality of lifeStigmaTuberculosis

Identifiers

PMID39681908
PMCPMC11622986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.